Cas:1261943-49-0 3-(4-hydroxyphenyl)-N-methylbenzamide manufacturer & supplier

Chemical Name:3-(4-hydroxyphenyl)-N-methylbenzamide

CAS.NO:1261943-49-0

Synonyms:3-(4-hydroxyphenyl)-N-methylbenzamide

Molecular Formula:C₁₄H₁₃NO₂

Molecular Weight:227.25900

HS Code:2924299090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:52.82000

Exact Mass:227.09500

LogP:2.99360

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(4-hydroxyphenyl)-N-methylbenzamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-hydroxyphenyl)-N-methylbenzamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(4-hydroxyphenyl)-N-methylbenzamide Use and application,3-(4-hydroxyphenyl)-N-methylbenzamide technical grade,usp/ep/jp grade.

Related News: ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment��s chemistry, manufacturing and controls process, but not its safety. 3-(4-hydroxyphenyl)-N-methylbenzamide manufacturer We also have to consider the degree of concentration and which temperature allows a high quality of API to be manufactured efficiently. 3-(4-hydroxyphenyl)-N-methylbenzamide supplier Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. 3-(4-hydroxyphenyl)-N-methylbenzamide vendor Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. 3-(4-hydroxyphenyl)-N-methylbenzamide factory Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion.